Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease : Clinical Journal of the American Society of Nephrology

Journal Logo

Original Articles: Glomerular and Tubulointerstitial Diseases

Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease

Caravaca-Fontán, Fernando1,2; Díaz-Encarnación, Montserrat M.3; Lucientes, Laura4; Cavero, Teresa5; Cabello, Virginia6; Ariceta, Gema7; Quintana, Luis F.8; Marco, Helena9; Barros, Xoana10; Ramos, Natalia11; Rodríguez-Mendiola, Nuria12; Cruz, Sonia13; Fernández-Juárez, Gema14; Rodríguez, Adela15; Pérez de José, Ana16; Rabasco, Cristina17; Rodado, Raquel18; Fernández, Loreto19; Pérez Gómez, Vanessa20; Ávila, Ana I.21; Bravo, Luis22; Lumbreras, Javier23; Allende, Natalia24; Sanchez de la Nieta, Maria Dolores25; Rodríguez, Eva26; Olea, Teresa27; Melgosa, Marta28; Huerta, Ana29; Miquel, Rosa30; Mon, Carmen31; Fraga, Gloria32; de Lorenzo, Alberto33; Draibe, Juliana34; Cano-Megías, Marta35; González, Fayna36; Shabaka, Amir37; López-Rubio, Maria Esperanza38; Fenollosa, María Ángeles39; Martín-Penagos, Luis40; Da Silva, Iara3; Alonso Titos, Juana41; Rodríguez de Córdoba, Santiago42; Goicoechea de Jorge, Elena3,42; Praga, Manuel1,2;  on behalf of the Spanish Group for the Study of Glomerular Diseases GLOSEN

Author Information
CJASN 15(9):p 1287-1298, September 2020. | DOI: 10.2215/CJN.15241219
  • Buy
  • Infographic
  • SDC

Abstract

Copyright © 2020 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid